Home > Insider Trading > Filing (0001477932-17-003817)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1506251	Citius Pharmaceuticals Inc.	CTXR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1463414	L Leonard Mazur	C//O Citius Pharmaceuticals, Inc. 11 Commerce Drive, 1St Floor Cranford NJ 07016	Executive Chairman	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-08-08	421,400	$4.13	1,779,663	No	4	P	Direct
Common Stock	Acquisiton	2017-08-08	1,547,067	$3.09	3,326,730	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	C	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2017-08-08	421,400	$0.01	421,400	$4.13
Common Stock	Convertible Promissory Note	Acquisiton	2017-08-08	1,547,067	$0.00	1,547,067	$3.09
Common Stock	Convertible Promissory Note	Disposition	2017-08-08	1,547,067	$0.00	1,547,067	$3.09

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
421,400	2018-02-08	2022-08-08	No	4	P	Direct
1,547,067	2017-08-08	2017-12-31	No	4	A	Direct
0	2017-08-08	2017-12-31	No	4	C	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Warrant to Purchase Common Stock	$6.15	2019-06-12	19,614	19,614	Direct
Common Stock	Warrant to Purchase Common Stock	$9.90	2019-09-30	3,171	3,171	Direct
Common Stock	Warrant to Purchase Common Stock	$9.90	2020-01-08	4,984	4,984	Direct
Common Stock	Warrant to Purchase Common Stock	$7.50	2020-08-18	35,211	35,211	Direct
Common Stock	Warrant to Purchase Common Stock	$7.50	2020-11-02	20,783	20,783	Direct
Common Stock	Warrant to Purchase Common Stock	$7.50	2020-11-20	20,664	20,664	Direct
Common Stock	Warrant to Purchase Common Stock	$7.50	2021-01-08	13,679	13,679	Direct
Common Stock	Warrant to Purchase Common Stock	$7.50	2021-03-14	4,210	4,210	Direct
Common Stock	Warrant to Purchase Common Stock	$6.15	2021-03-15	18,106	18,106	Direct
Common Stock	Options to Purchase Common Stock	$6.75	2024-09-12	220,000	220,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2019-06-12	19,614	19,614	Direct
2019-09-30	3,171	3,171	Direct
2020-01-08	4,984	4,984	Direct
2020-08-18	35,211	35,211	Direct
2020-11-02	20,783	20,783	Direct
2020-11-20	20,664	20,664	Direct
2021-01-08	13,679	13,679	Direct
2021-03-14	4,210	4,210	Direct
2021-03-15	18,106	18,106	Direct
2024-09-12	220,000	220,000	Direct

Footnotes

On August 8, 2017, the Reporting Person purchased a five-year warrant to purchase 421,400 shares of the Company's common stock at an exercise price of $4.125 per share. The warrant is fully vested and exercisable six months from August 8, 2017.
On August 8, 2017, the Reporting Person converted $4,710,000 of outstanding convertible promissory notes and accrued interest of $76,240 into shares of common stock at a conversion price per share of $3.09, which was 75% of the price per share paid by investors in the Company's public offering that was completed on August 8, 2017 as set forth in the terms of the convertible promissory notes.
The warrant is fully vested and exercisable immediately.
The option vests as to 40% of the shares of the Company's common stock on September 12, 2014 and 15% of the shares on each of September 12, 2015, March 12 and September 12, 2016 and September 12, 2017. The option was issued pursuant to the Company's 2014 Stock Incentive Plan.